APONTIS PHARMA AG, DE000A3CMGM5

APONTIS PHARMA AG, DE000A3CMGM5

20.09.2022 - 07:33:36

EQS-News: APONTIS PHARMA announces cooperation to launch new Single Pill in Germany

T: +49 2173 89 55 4900 F: +49 2173 89 55 1521 Alfred-Nobel-Str. 10 40789 Monheim am Rhein Germanyapontis-pharma.deAPONTIS PHARMA Press Contact

CROSS ALLIANCE communication GmbH Sven Paulyir@apontis-pharma.de T: +49 89 125 09 0330

20.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: APONTIS PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim

Germany E-mail: ir@apontis-pharma.de Internet: https://apontis-pharma.de/ ISIN: DE000A3CMGM5 WKN: A3CMGM Listed: Regulated Unofficial Market in Frankfurt (Scale) EQS News ID: 1445135 ? End of News EQS News Service

1445135??20.09.2022?CET/CEST

@ dgap.de